Inhibikase Therapeutics, Inc. — DEFA14A Filings
7 DEFA14A filings on record
This page lists all DEFA14A filings submitted to the SEC by Inhibikase Therapeutics, Inc. (IKT), sorted by most recent first. Each row links to the full filing on EdgarLookup. Inhibikase Therapeutics, Inc. has filed 7 DEFA14A documents with the SEC since 2018. To view all SEC filings by Inhibikase Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
3
3/A
4
4/A
424B3
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFR14A
DRS
DRS/A
DRSLTR
EFFECT
POS AM
PRE 14A
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-8
SC 13D
SC 13G
SC 13G/A
SC 14F1
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEFA14A | DEFA14A | 0001193125-25-139929 | Jun 12, 2025 | — |
| DEFA14A | DEFA14A | 0000950170-25-069199 | May 12, 2025 | — |
| DEFA14A | DEFA14A | 0000950170-24-076301 | Jun 21, 2024 | — |
| DEFA14A | DEFA14A | 0000950170-24-049213 | Apr 26, 2024 | — |
| DEFA14A | DEFA14A | 0000950170-23-021783 | May 12, 2023 | — |
| DEFA14A | DEFA14A | 0000950170-22-006985 | May 3, 2022 | — |
| DEFA14A | DEFA14A | 0001193125-21-145703 | Apr 30, 2021 | — |